| Cerebrovascular Accident |
1 |
1 |
| Thromboembolism |
0 |
1 |
| Ischemic Stroke |
0 |
0.81 |
| CT Angiography |
0 |
0.3 |
| Cardiovascular Imaging |
0 |
0.28 |
| CT Scan |
0 |
0.27 |
| Thrombolytic Therapy |
0 |
0.24 |
| Acute Myocardial Infarction (MI) |
0 |
0.2 |
| Thrombectomy |
0 |
0.2 |
| Tissue Plasminogen Activator |
0 |
0.17 |
| Hospital |
0 |
0.16 |
| Myocardial Infarction (MI) |
0 |
0.15 |
| Angiography |
0 |
0.12 |
| Cervical Region |
0 |
0.12 |
| Heart |
0 |
0.12 |
| Infarction |
0 |
0.12 |
| Tissue |
0 |
0.12 |
| Acute Stroke |
0 |
0.08 |
| Brain |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Professional Development |
0 |
0.08 |
| Residency |
0 |
0.08 |
| Magnetic Resonance Imaging |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Middle Cerebral Artery |
0 |
0.06 |
| A-Scan Biometry |
0 |
0.04 |
| Adverse Effects |
0 |
0.04 |
| Artery |
0 |
0.04 |
| Attending Physician |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Intensive Care Unit |
0 |
0.04 |
| Maryland |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Triage |
0 |
0.04 |
| Care and Maintenance of Vision |
0 |
0.02 |
| Cataract |
0 |
0.02 |